Australia markets open in 3 hours 12 minutes

T2 Biosystems, Inc. (TTOO)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3300-0.0100 (-0.75%)
At close: 4:00PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
9,843
8,335
10,500
4,666
4,080
Cost of revenue
14,526
16,763
15,404
12,028
6,872
Gross profit
-4,683
-8,428
-4,904
-7,362
-2,792
Operating expenses
Research development
17,295
16,326
14,489
23,733
24,009
Selling general and administrative
25,136
27,304
25,697
22,757
24,077
Total operating expenses
42,431
43,630
40,186
46,490
48,086
Operating income or loss
-47,114
-52,058
-45,090
-53,852
-50,878
Interest expense
6,826
7,348
6,682
8,907
4,098
Total other income/expenses net
94
400
619
331
172
Income before tax
-53,846
-59,006
-51,153
-62,428
-54,804
Income from continuing operations
-53,846
-59,006
-51,153
-62,428
-54,804
Net income
-53,846
-59,006
-51,153
-62,428
-54,804
Net income available to common shareholders
-53,846
-59,006
-51,153
-62,428
-54,804
Basic EPS
-
-1.30
-1.26
-1.94
-2.11
Diluted EPS
-
-1.30
-1.26
-1.94
-2.11
Basic average shares
-
45,508
40,559
32,132
26,016
Diluted average shares
-
45,508
40,559
32,132
26,016
EBITDA
-
-48,016
-42,022
-50,581
-48,426